Similar articles

• New Delhi metallo-β-lactamase and multidrug resistance: a global SOS?

  Bonomo RA. Bonomo RA. Clin Infect Dis. 2011 Feb 15;52(4):485-7. doi: 10.1093/cid/ciq179. Clin Infect Dis. 2011. PMID: 21258101 No abstract available.
• Comparative in vitro killing of carbapenems and aztreonam against Klebsiella pneumoniae producing VIM-1 metallo-beta-lactamase.

  Panagiotakopoulou A, Daikos GL, Miriagou V, Loli A, Tzelepi E, Tzouvelekis LS. Panagiotakopoulou A, et al. Int J Antimicrob Agents. 2007 Mar;29(3):360-2. doi: 10.1016/j.ijantimicag.2006.11.004. Epub 2007 Jan 12. Int J Antimicrob Agents. 2007. PMID: 17223016 No abstract available.
• Resistance in gram-negative bacteria: enterobacteriaceae.

  Paterson DL. Paterson DL. Am J Med. 2006 Jun;119(6 Suppl 1):S20-8; discussion S62-70. doi: 10.1016/j.amjmed.2006.03.013. Am J Med. 2006. PMID: 16735147 Review.
• Activity of cefepime and carbapenems in experimental pneumonia caused by porin-deficient Klebsiella pneumoniae producing FOX-5 beta-lactamase.

  Pichardo C, del Carmen Conejo M, Bernabéu-Wittel M, Pascual A, Jiménez-Mejías ME, de Cueto M, Pachón-Ibáñez ME, García I, Pachón J, Martínez-Martínez L. Pichardo C, et al. Clin Microbiol Infect. 2005 Jan;11(1):31-8. doi: 10.1111/j.1469-0691.2004.01018.x. Clin Microbiol Infect. 2005. PMID: 15649301
• [Pseudomonas aeruginosa infection].

  Oishi K. Oishi K. Nihon Rinsho. 2003 Feb;61 Suppl 2:423-7. Nihon Rinsho. 2003. PMID: 12722255 Review. Japanese. No abstract available.